Drugs / FAB-6011
last change Mar 2012 re-read 3 minutes ago

FAB-6011

Vaccine

Developed for
influenza
Investigated by
Fluart Innovative Vaccine Ltd, Hungary

Trials 2

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01459276 Oct → Dec 2011 influenza Fluart Innovative Vaccine Ltd, Hungary Completed No outcome recorded
— NCT01408290 Sep → Oct 2011 influenza Fluart Innovative Vaccine Ltd, Hungary Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as FAB-6011 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01408290 ↗
1

NCT01459276 ↗

Modality Vaccine “FAB-6011 trivalent influenza vaccine” NCT01408290 ↗